Phio Pharmaceuticals Corp. (PHIO) SEC Filings — 2024

Filings

• Phio Pharmaceuticals Corp. Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 26, 2024
• Phio Pharmaceuticals Corp. Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 20, 2024
• Phio Pharmaceuticals Files 8-K — 8-K · Dec 19, 2024
• Phio Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
• Phio Pharmaceuticals Corp. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
• Phio Pharmaceuticals Files 8-K — 8-K · Nov 7, 2024
• Phio Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
• Phio Pharmaceuticals Corp. Board Changes and Officer Compensation — 8-K · Aug 1, 2024
• Phio Pharmaceuticals Files S-1 Registration — S-1 · Jul 26, 2024
• Phio Pharmaceuticals to be Acquired by 03 Life Sciences — 8-K · Jul 24, 2024
• Phio Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — 8-K · Jul 12, 2024
• Phio Pharmaceuticals Terminates 03 Life Sciences License — 8-K · Jul 5, 2024
• Phio Pharmaceuticals Files 8-K — 8-K · Jul 2, 2024
• Phio Pharmaceuticals to be Acquired by Fulcrum Therapeutics — 8-K · Jun 21, 2024
• Phio Pharmaceuticals to be Acquired by 03 Life Sciences — 8-K · May 28, 2024
• Phio Pharmaceuticals Corp. Files 8-K with Material Agreement — 8-K · May 17, 2024
• Phio Pharmaceuticals Corp. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024
• Phio Pharmaceuticals Corp. Announces 2024 Annual Meeting of Stockholders on June 17 — DEF 14A · May 8, 2024
• Phio Pharmaceuticals Files 8-K on Financials — 8-K · Apr 2, 2024
• Phio Pharmaceuticals Corp. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
• INTRACOASTAL CAPITAL Amends Phio Pharma Stake (SC 13G/A) — SC 13G/A · Feb 6, 2024
• PHIO Receives Nasdaq Delisting Notice for Bid Price Non-Compliance — 8-K · Jan 26, 2024